not so +ve tiz1..... this redirection provides a hint at the consequence of the hard shell cap formulation, the trial with GPs and the Tas Health deal.... Neuvis seems to have come to nothing. So they dump Neuvis and start all over again from scratch.
I'm also not keen on outsourcing when we have appointed experts on the Advisory Panel who should be working with employees, well experienced in such.....
AC8 Price at posting:
8.8¢ Sentiment: Hold Disclosure: Held